• Help Desk
  • Contact Us
IDDI
  • Our Solutions
    • Strategic Consulting
      • Study Design
      • Biomarker-IVD Validation
      • Precision Medicine
    • eClinical Solutions
      • Randomization & Trial Supply Management
      • Electronic Data Capture
    • Clinical Data Management
      • Data Standards Implementation – SDTM
    • Biostatistics
      • Biostatistical Analysis
      • Interim Analyses – DMC
      • Data Standards Implementation – ADaM
      • Scientific publications
  • Why IDDI
    • IDDI Leadership
    • Teams
    • History
    • News & Events
    • IDDI Experience
    • Partnerships
    • Research Projects
      • Benefit
  • Resources
    • Webinars
    • Podcasts
    • Videos
    • Brochures
    • Featured Articles
    • White Papers
    • Case Studies
  • Careers
    • IDDI Culture
    • Jobs
  • Help Desk
  • Contact Us
  • Submit RFI
Home » biostatistical analyses

Independent Analyses To Inform Go/No-go Decisions

Publié le March 21, 2017

Our client in this case was an investment organization specialized in biotechnology companies, and they required an urgent analysis of…

Lire la suite

Clinical Validity Of Circulating Tumor Cells (CTC)

Publié le March 21, 2017

Assessment of Clinical Validity of Circulating Tumor Cells (CTC) Quantification Clinical Validity Of Circulating Tumor Cells (CTC) In Patients With…

Lire la suite

Developing New Biomarkers And Diagnostic Tests

Publié le March 21, 2017

Biostatistical Expertise For Developing New Biomarkers And Diagnostic Tests IDDI has a long-term collaboration with a Sponsor to provide biostatistical…

Lire la suite

Meta-Analysis To Assess Efficacy in Colorectal Cancer

Publié le March 21, 2017

In this meta-analysis, tumor responses and survival were analyzed combining the data from the different trials using patient individual data. The…

Lire la suite

Jumping Ahead to Phase III trial

Publié le March 21, 2017

A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…

Lire la suite

Meta-Analysis of Clinical Trials to Support New Drug Approval

Publié le March 21, 2017

Meta-Analysis performed with IDDI’s Methodology Skills IDDI has been involved in numerous meta-analyses to directly or indirectly support new drug applications….

Lire la suite

Anti-cancer drug approved based on a surrogate endpoint

Publié le March 16, 2017

Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…

Lire la suite

Subscribe to our newsletter
  • Our Solutions
    • Strategic Consulting
      • Study Design
      • Biomarker-IVD Validation
      • Precision Medicine
    • eClinical Solutions
      • Randomization & Trial Supply Management
      • Electronic Data Capture
    • Clinical Data Management
      • Data Standards Implementation – SDTM
    • Biostatistics
      • Biostatistical Analysis
      • Interim Analyses – DMC
      • Data Standards Implementation – ADaM
      • Scientific publications
  • Why IDDI
    • IDDI Leadership
    • Teams
    • History
    • News & Events
    • IDDI Experience
    • Partnerships
    • Research Projects
      • Benefit
  • Resources
    • Webinars
    • Podcasts
    • Videos
    • Brochures
    • Featured Articles
    • White Papers
    • Case Studies
  • Careers
    • IDDI Culture
    • Jobs
  • Help Desk
  • Contact Us
  • Submit RFI

Contact Us

  • IDDI Head Office

    Avenue Provinciale, 30
    1341 Louvain-la-Neuve
    Belgium

    View Map ›
  • Tel.: +32 (0) 10 61 44 44
  • info@iddi.com

 

  • IDDI Inc

    7751 Brier Creek Parkway
    Suite 204
    Raleigh, NC 27617

    View Map ›
  • Tel.: +1 984 227 8599
  • info@iddi.com

IDDI

 

International Drug Development Institute (IDDI)
IDDI brings the full spectrum of study design, clinical data collection, analysis and reporting to your clinical development programs.

Copyright © 2023 IDDI. All rights reserved
Privacy Statement  |  Cookie Policy  |  Sitemap